Changes in predicted cardiovascular disease risk after biliopancreatic diversion surgery in severely obese patients.
第一作者:
Marie-Ève,Piché
第一单位:
Quebec Heart and Lung Institute/Laval University, Québec, Canada.
作者:
关键词
ATP IIIAdult Treatment Panel IIIBMIBPD-DSBariatric surgeryBiliopancreatic diversion with duodenal switchBody mass indexCHDCVDCardiovascular diseaseCardiovascular riskCoronary heart diseaseHOMA insulin resistance modelHOMA-IRHigh sensitive C-reactive proteinHs-CRPMetabolic profileNIHNational Institute of HealthSOSSeverely obeseSwedish Obese Subjects group
主题词
成年人(Adult);抗高血压药(Antihypertensive Agents);载脂蛋白类(Apolipoproteins);胆胰分泌转流术(Biliopancreatic Diversion);血糖(Blood Glucose);人体质量指数(Body Mass Index);C反应蛋白质(C-Reactive Protein);心血管疾病(Cardiovascular Diseases);胆固醇, HDL(Cholesterol, HDL);胆固醇, LDL(Cholesterol, LDL);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);降血糖药(Hypoglycemic Agents);降血脂药物(Hypolipidemic Agents);胰岛素(Insulin);男(雄)性(Male);中年人(Middle Aged);肥胖症, 病态(Obesity, Morbid);危险性评估(Risk Assessment);危险因素(Risk Factors);时间因素(Time Factors);甘油三酯类(Triglycerides);体重减轻(Weight Loss)
DOI
10.1016/j.metabol.2013.09.004
PMID
24120264
发布时间
2022-12-07
- 浏览97

Metabolism
79-86页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文